Business Description
Solesence Inc
NAICS : 811490
SIC : 2844
ISIN : US6300791018
Total Employee Number:
115Description
Solesence Inc is a health-oriented, science-driven company, focused on various skin health, beauty and wellness markets. Its primary skin health products are fully developed prestige skin care formulations with mineral-based UV protection enabled by proprietary Active Pharmaceutical Ingredients, which are also marketed as APIs for sale to manufacturers of other types of skin health products, including sunscreens and daily care products. Additionally, it continues to sell products in legacy markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. The company operates as a single business segment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.31 | |||||
Debt-to-EBITDA | 7.38 | |||||
Interest Coverage | 0.8 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.03 | |||||
Beneish M-Score | 14.19 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4 | |||||
3-Year FCF Growth Rate | -17.6 | |||||
3-Year Book Growth Rate | 29.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 13.76 | |||||
9-Day RSI | 24.99 | |||||
14-Day RSI | 32.16 | |||||
3-1 Month Momentum % | 38.17 | |||||
6-1 Month Momentum % | -27.03 | |||||
12-1 Month Momentum % | -71.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.08 | |||||
Quick Ratio | 0.7 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 159.04 | |||||
Days Sales Outstanding | 52.04 | |||||
Days Payable | 49.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.7 | |||||
Shareholder Yield % | -10.89 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 26.52 | |||||
Operating Margin % | 1.34 | |||||
Net Margin % | 1.56 | |||||
EBITDA Margin % | 5 | |||||
FCF Margin % | -0.59 | |||||
OCF Margin % | 0.28 | |||||
ROE % | 5.54 | |||||
ROA % | 1.76 | |||||
ROIC % | 1.8 | |||||
3-Year ROIIC % | 21.16 | |||||
ROC (Joel Greenblatt) % | 5.12 | |||||
ROCE % | 6.02 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 79.71 | |||||
PE Ratio without NRI | 79.71 | |||||
PS Ratio | 0.97 | |||||
PB Ratio | 3.32 | |||||
Price-to-Tangible-Book | 3.33 | |||||
Price-to-Operating-Cash-Flow | 797.1 | |||||
EV-to-EBIT | 38.35 | |||||
EV-to-EBITDA | 25.85 | |||||
EV-to-Revenue | 1.29 | |||||
EV-to-FCF | -218.52 | |||||
Price-to-GF-Value | 0.45 | |||||
Price-to-Median-PS-Value | 0.49 | |||||
Price-to-Graham-Number | 3.47 | |||||
Earnings Yield (Greenblatt) % | 2.61 | |||||
FCF Yield % | -0.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SLSN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Solesence Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 60.396 | ||
| EPS (TTM) ($) | 0.01 | ||
| Beta | 1.6654 | ||
| 3-Year Sharpe Ratio | 0.36 | ||
| 3-Year Sortino Ratio | 0.75 | ||
| Volatility % | 71.77 | ||
| 14-Day RSI | 32.16 | ||
| 14-Day ATR ($) | 0.140425 | ||
| 20-Day SMA ($) | 1.21615 | ||
| 12-1 Month Momentum % | -71.22 | ||
| 52-Week Range ($) | 0.7656 - 4.55 | ||
| Shares Outstanding (Mil) | 70.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Solesence Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Solesence Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-11 08:30 | In 135 days | ||
| Third quarter earnings results for 2026 | 2026-11-11 | In 134 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-31 17:00 | In 32 days | ||
| Second quarter earnings results for 2026 | 2026-07-31 | In 31 days | ||
| First quarter earnings conference call for 2026 | 2026-05-12 08:30 | 1.50 (+9.49%) | ||
| First quarter earnings results for 2026 | 2026-05-12 | 1.50 (+9.49%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-31 08:30 | 0.90 (-7.21%) | ||
| Annual report for 2025 | 2026-03-31 | 0.90 (-7.21%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-31 | 0.90 (-7.21%) | ||
| Third quarter earnings conference call for 2025 | 2025-11-11 08:30 | 2.81 (-11.41%) |
Show
Entries
Solesence Inc Frequently Asked Questions
What is Solesence Inc(SLSN)'s stock price today?
The current price of SLSN is $0.80. The 52 week high of SLSN is $4.55 and 52 week low is $0.77.
When is next earnings date of Solesence Inc(SLSN)?
The next earnings date of Solesence Inc(SLSN) is 2026-07-31 Est..
Does Solesence Inc(SLSN) pay dividends? If so, how much?
Solesence Inc(SLSN) does not pay dividend.
Guru Commentaries on NAS:SLSN
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Nanophase Technologies Corporation (OTC: NANX) | 2024-08-08 |
Articles on Solesence Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers